These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18826209)

  • 1. pKa prediction of monoprotic small molecules the SMARTS way.
    Lee AC; Yu JY; Crippen GM
    J Chem Inf Model; 2008 Oct; 48(10):2042-53. PubMed ID: 18826209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can descriptors of the electron density distribution help to distinguish functional groups?
    Burton J; Meurice N; Leherte L; Vercauteren DP
    J Chem Inf Model; 2008 Oct; 48(10):1974-83. PubMed ID: 18831545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of adverse drug reactions using decision tree modeling.
    Hammann F; Gutmann H; Vogt N; Helma C; Drewe J
    Clin Pharmacol Ther; 2010 Jul; 88(1):52-9. PubMed ID: 20220749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical molecular design: a tool to follow up hits from small-molecule screening.
    Lindgren AE; Larsson A; Linusson A; Elofsson M
    Methods Mol Biol; 2014; 1056():169-88. PubMed ID: 24306873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
    Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
    Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning models for lipophilicity and their domain of applicability.
    Schroeter T; Schwaighofer A; Mika S; Laak AT; Suelzle D; Ganzer U; Heinrich N; Müller KR
    Mol Pharm; 2007; 4(4):524-38. PubMed ID: 17637064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of reliable aqueous solubility models and their application in druglike analysis.
    Wang J; Krudy G; Hou T; Zhang W; Holland G; Xu X
    J Chem Inf Model; 2007; 47(4):1395-404. PubMed ID: 17569522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmarking and validating algorithms that estimate pK(a) values of drugs based on their molecular structures.
    Meloun M; Bordovská S
    Anal Bioanal Chem; 2007 Oct; 389(4):1267-81. PubMed ID: 17676314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships.
    Cheng A; Merz KM
    J Med Chem; 2003 Aug; 46(17):3572-80. PubMed ID: 12904062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scaffold tree: an efficient navigation in the scaffold universe.
    Ertl P; Schuffenhauer A; Renner S
    Methods Mol Biol; 2011; 672():245-60. PubMed ID: 20838972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fully computational model for predicting percutaneous drug absorption.
    Neumann D; Kohlbacher O; Merkwirth C; Lengauer T
    J Chem Inf Model; 2006; 46(1):424-9. PubMed ID: 16426076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico pKa prediction and ADME profiling.
    Cruciani G; Milletti F; Storchi L; Sforna G; Goracci L
    Chem Biodivers; 2009 Nov; 6(11):1812-21. PubMed ID: 19937818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification models for safe drug molecules.
    Madan AK; Bajaj S; Dureja H
    Methods Mol Biol; 2013; 930():99-124. PubMed ID: 23086839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products.
    Murray JB; Roughley SD; Matassova N; Brough PA
    J Med Chem; 2014 Apr; 57(7):2845-50. PubMed ID: 24520903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pKa estimation methods on 211 druglike compounds.
    Manchester J; Walkup G; Rivin O; You Z
    J Chem Inf Model; 2010 Apr; 50(4):565-71. PubMed ID: 20225863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of HPLC retention index using artificial neural networks and IGroup E-state indices.
    Albaugh DR; Hall LM; Hill DW; Kertesz TM; Parham M; Hall LH; Grant DF
    J Chem Inf Model; 2009 Apr; 49(4):788-99. PubMed ID: 19309176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.